Clinical Trials Browser

Phase 2 × Gastrointestinal Neoplasms × Oxaliplatin × Clear all

Gastrointestinal Neoplasms

NCT03929666 2025-09-12

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05494060 2023-11-07

EXPLORING

Phase 2 Recruiting

80 enrolled

Gastrointestinal

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT04080843 2022-07-13

ALTER-C-002

Phase 2 Completed

30 enrolled

Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

NCT02241499 2020-02-28

PALAESTRA

Phase 2 Completed

29 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms

NCT01129310 2019-02-25